Po-Jung Su

3PUBLICATIONS
14CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 09, 2026
Benign Growth, Malignant Protection? Insights into Benign Prostatic Hyperplasia and Prostate Cancer.

Po-Jung Su, I-Hung Shao, Yu-Hsiang Lin

|Aug 14, 2025
Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning.

Dong-Yi Chen, Chun-Chi Chen, Ming-Lung Tsai

|Nov 08, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.

Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang

Pageof 1

Frequent Collaborators

1 joint publications

Pei-Hung Chang

1 joint publications

Wen-Kuan Huang

1 joint publications

Edward Chia-Cheng Lai

1 joint publications

Dong-Yi Chen